New Industry Ventures Develops Innovative System of Production Video Analytics
The RBV Capital Fund, created with the participation of capital RVC  and R-Pharm, invested 105 million rubles in PanDx, which is developing a multifunctional catheter “Izikat” for the treatment of severe diseases of the gastrointestinal tract.
Intellojik has attracted 160 million roubles of investment in round B in order to further develop the artificial intelligence platform for medical research analysis Botkin.AI.
The volume of the venture transactions market in Russia in the first half of 2020 decreased by 9% to 240 million dollars, compared to 262.8 million dollars in the first half of 2019. At the same time, the number of transactions decreased by almost one and a half times — from 130 to 78 transactions. About 90% of the total investment during this period was in the expansion phase.
The RVC Biofund closed the deal to sell its 17.79% stake in the Genetico portfolio company Center for Genetics and Reproductive Medicine (hereinafter — Genetico).
According to the results of the assessment of the investment portfolio of RVC as of the end of the third quarter of 2020, the return on capital indicator (TVPI) exceeded the figure of one.
On October 30, Deputy General Director — Investment Director of RVC Alexey Basov spoke at the plenary session of the 14th Siberian Venture Fair “Venture Industry — Who and In Which Way Invests in Biotech and Pharma?”.
GamesBoost42, a global start-up finance company, has opened a $5 million credit line for the portable mini projector manufacturer Cinemood. Pinewood (on the Russian market — “Multikubik”) is part of the Russian-Belarusian Venture Investment Fund portfolio and the Far East High-Tech Fund, created with RVC capital participation.

1 2 3 4 5 ... 12 Next
News for 2021: January February March April

Search by name:

Search by date:

Select date in calendar
Select date in calendar